Table 2 Perioperative details comparing patients who underwent radical resections following NACT (n = 126) from group 1 with patients who underwent upfront surgery (n = 62) from group 2
From: D2 lymphadenectomy is not only safe but necessary in the era of neoadjuvant chemotherapy
Resected patients from group 1 (n = 126) | Resected patients from group 2 (n = 62) | ||
|---|---|---|---|
Median age in years (range) | 53 (22 to 77) | 58 (28 to 82) | P <0.02 |
Sex (M:F) | 87:39 (69%:31%) | 48:14 (77%:23%) | P <0.33 |
Surgeries | |||
Total gastrectomy | 17 | 6 | P <0.015 |
Proximal gastrectomy | 30 | 5 | |
Subtotal gastrectomy | 79 | 51 | |
Median blood loss in ml (range) | 500 (150 to 1700) | 400 (50 to 900) | P <0.24 |
Median units of blood transfused (range) | 0 (0 to 2) | 0 (0 to 2) 0.88 | P <0.88 |
Median lymph nodes (range) | 16 (1 to 53) | 18 (3 to 39) | P <0.25 |
Morbidity rate | 12% (15) | 22.6% (14) | P <0.056 |
Mortality rate | 0% (0) | 0% (0) | - |
Median duration of hospital stay in days (range) | 9 (6 to 28) | 11 (6 to 43) | P <0.001 |